Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy

BackgroundChronic migraine (CM) affects about the 2% of the general population and it has been recognized as one of the most-disabling conditions worldwide by the World Health Organization. CM is often associated with the overuse of abortive medication, which determines the worsening of headache its...

Full description

Bibliographic Details
Main Authors: Simona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, Michela Maria Cainazzo, Andrea Negro, Paolo Martelletti, Luigi Alberto Pini
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Neurology
Subjects:
chronic migraine
OnabotulinumtoxinA
long-term treatment
quality of life
tolerance
headache
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00586/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2017.00586/full

Similar Items